Archives for July 20, 2005

← 2005

Millipore posts stronger revenue, but profits close

Manufacturing consolidation and acquisition costs helped reduce net income as Millipore revealed its 2005 second quarter financial results. The company has just completed the purchase of two companies with the intention of increasing its presence in...

Merrion issued drug delivery patent

Oral drug delivery specialists, Merrion Pharmaceuticals, have been issued with a patent that covers new peptide compounds which can be physically or chemically complexed with an active substance, either a drug or a biological, in order to improve...

BioGenex launches the Xmatrx

BioGenex announces the launch of the Xmatrx, a walk-away system for automation of FISH, ISH, and IHC for molecular diagnostics and therapeutic target identification and validation as well as cell and tissue staining applications, proving ideal for...

Sosei deal beefs up Japanese presence

Japanese biopharmaceutical company Sosei, is to acquire UK-based Arakis, in a £106.5 million deal that includes a £213 million ($375 million) global partnership with Novartis for its lead product, a once daily, inhaled, long-acting antimuscarinic...

Occam obtains CE approval for stent

Biosensors International Group has announced that its Netherlands-based subsidiary, Occam International B.V. has received Conformite Europeene (CE) Mark approval for the Group's first drug eluting stent (DES), Axxion.

UCLA chemists create Nano Valve

UCLA chemists have created the first nano valve that can be opened and closed at will to trap and release molecules. The nano valve could potentially be used as a drug delivery system, trapping and releasing therapeutic molecules on demand.

New Sanofi plant increases vaccine production

Sanofi Pasteur is to increase US influenza vaccine capacity as plans to construct a new plant get underway. The new facility is expected to be up and running in time for the 2009 influenza season creating more than 100 new production jobs.